160 related articles for article (PubMed ID: 26363526)
1. GRIM-19 expression is a potent prognostic marker in colorectal cancer.
Hao M; Shu Z; Sun H; Sun R; Wang Y; Liu T; Ji D; Cong X
Hum Pathol; 2015 Dec; 46(12):1815-20. PubMed ID: 26363526
[TBL] [Abstract][Full Text] [Related]
2. [Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].
Gong LB; Luo XL; Liu SY; Tao DD; Gong JP; Hu JB
Ai Zheng; 2007 Jul; 26(7):683-7. PubMed ID: 17626740
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of GRIM-19 in lung cancer.
Fan XY; Jiang ZF; Cai L; Liu RY
Med Oncol; 2012 Dec; 29(5):3183-9. PubMed ID: 22573109
[TBL] [Abstract][Full Text] [Related]
4. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
6. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
7. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of IRF-2 expression in colorectal cancer.
Mei Z; Wang G; Liang Z; Cui A; Xu A; Liu Y; Liu C; Yang Y; Cui L
Oncotarget; 2017 Jun; 8(24):38969-38977. PubMed ID: 28465494
[TBL] [Abstract][Full Text] [Related]
9. Expression of GW112 and GRIM-19 in colorectal cancer tissues.
Chen H; Wu Q
J BUON; 2015; 20(2):438-42. PubMed ID: 26011333
[TBL] [Abstract][Full Text] [Related]
10. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
11. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
13. High Rab27A expression indicates favorable prognosis in CRC.
Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma.
Li F; Ren W; Zhao Y; Fu Z; Ji Y; Zhu Y; Qin C
Med Oncol; 2012 Dec; 29(5):3046-54. PubMed ID: 22492280
[TBL] [Abstract][Full Text] [Related]
16. Sarco/endoplasmic reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer.
Chung FY; Lin SR; Lu CY; Yeh CS; Chen FM; Hsieh JS; Huang TJ; Wang JY
Am J Surg Pathol; 2006 Aug; 30(8):969-74. PubMed ID: 16861967
[TBL] [Abstract][Full Text] [Related]
17. HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.
Liu Y; Zhou J; Zhang C; Fu W; Xiao X; Ruan S; Zhang Y; Luo X; Tang M
Int J Clin Exp Pathol; 2014; 7(3):969-77. PubMed ID: 24696714
[TBL] [Abstract][Full Text] [Related]
18. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of GRIM-19 in epithelial ovarian carcinoma].
Shao YP; Cheng XD; Wan XY
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):751-5. PubMed ID: 23302733
[TBL] [Abstract][Full Text] [Related]
20. A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas.
Alchanati I; Nallar SC; Sun P; Gao L; Hu J; Stein A; Yakirevich E; Konforty D; Alroy I; Zhao X; Reddy SP; Resnick MB; Kalvakolanu DV
Oncogene; 2006 Nov; 25(54):7138-47. PubMed ID: 16732315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
